Association of antidiabetic therapy with shortened telomere length in middle-aged Type 2 diabetic patients.

Published in: Journal of diabetes and metabolic disorders (2021)

The results revealed that Doanil therapy was more effective in managing diabetic risk and limiting the shortening telomere length than insulin therapy.

Keyphrases

type diabetes
middle aged
adipose tissue
metabolic syndrome
single cell
cell therapy
skeletal muscle
mesenchymal stem cells